2025-12-28 - Analysis Report
Okay, here's a comprehensive analysis of First Solar Inc. (FSLR) based on the data provided.

**1) Return Rate Comparison**

*   **Company Overview:** First Solar Inc. is a leading global provider of photovoltaic (PV) solar energy solutions.
*   **FSLR Cumulative Return:** 94.32%
*   **VOO (S&P 500) Cumulative Return:** 103.21%
*   **Divergence:** -8.5 (Relative Divergence: 35.4)

**Analysis:**

*   FSLR has underperformed the S&P 500 (VOO) over the period for which cumulative returns are calculated.
*   The current divergence of -8.5% indicates that FSLR's return is lagging VOO.
*   The relative divergence of 35.4 suggests that the current divergence is not near the extreme low or high observed in the past, but is leaning towards the lower side of the divergence range.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD  | Alpha   | Beta   | Cap(B) |
|------------|----------|------|---------|--------|--------|
| 2015-2017  | 37.0%    | 67.2% | 9.0%    | 0.0    | 7.2    |
| 2016-2018  | -32.0%   | 73.3% | -47.0%  | -0.0   | 4.6    |
| 2017-2019  | 34.0%    | 73.3% | 11.0%   | -0.3   | 6.0    |
| 2018-2020  | 11.0%    | 81.1% | -13.0%  | -0.3   | 10.6   |
| 2019-2021  | 55.0%    | 81.1% | 8.0%    | -0.9   | 9.3    |
| 2020-2022  | 130.0%   | 81.1% | 131.0%  | 0.2    | 16.1   |
| 2021-2023  | 33.0%    | 80.7% | 31.0%   | 1.4    | 18.5   |
| 2022-2024  | 22.0%    | 84.0% | 1.0%    | 1.2    | 18.9   |
| 2023-2025  | -32.0%   | 84.0% | -100.0% | 3.1    | 28.9   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate (CAGR) shows significant variability, ranging from -32% to 130%. Recent periods (2023-2025) show negative growth.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating substantial risk and volatility. MDD hovers around 70-80%.
*   **Alpha:** Alpha is generally positive, indicating that FSLR has the potential to outperform its benchmark, but there are significant periods of underperformance (negative Alpha). The recent alpha is very negative (2023-2025).
*   **Beta:** Beta is fluctuating, in the 2023-2025 period, the Beta is extremely high.

**2) Recent Stock Price Fluctuations**

*   **Close:** 269.69
*   **Previous Close:** 272.21
*   **Change:** -0.93
*   **5-day SMA:** 272.57
*   **20-day SMA:** 262.87
*   **60-day SMA:** 252.14

**Analysis:**

*   The stock price closed lower than the previous day.
*   The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA.  This *could* suggest an upward trend, but the recent price decrease warrants caution.

**3) RSI, PPO, and Expected Return**

*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended)
*   **RSI:** 55.98
*   **PPO:** 0.33
*   **Hybrid Signal:** Buy 90% of cash
*   **Recent (20 days) relative divergence change:** 4.9 (+): Short-term Increase
*   **Expected Return:** 20.8%

**Analysis:**

*   **MRI:**  The MRI suggests a high investment recommendation, although this seems contradictory given other factors.
*   **RSI:** The RSI of 55.98 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** The PPO is slightly positive, indicating a possible emerging uptrend.
*   **Hybrid Signal:** The hybrid signal recommend to buy 90% of cash (1 shares - Safe - MRI:0.80), the MRI score is less than 1.0 which doesn't makes sense.
*   **Recent relative divergence change:** The recent increase in relative divergence suggests short-term positive momentum.
*   **Expected Return:** A high expected return of 20.8% is optimistic, especially considering the recent underperformance against the S&P 500.

**4) Recent News & Significant Events**

*   Multiple articles discuss FSLR's financial prospects, analyst forecasts, and a deal with Alphabet.
*   One article mentions a 30% surge in stock price (likely explaining the recent increase divergence mentioned above), while another mentions FSLR trading lower.
*   Greenup Street Wealth Management LLC purchased shares.

**Analysis:**

*   The news is mixed. There's positive news regarding a stock surge, a deal, and institutional investment. However, there's also news of the stock trading lower and caution in some analysis.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.67 (Buy)
*   **Opinions:** 32
*   **Target Price:** 274.61 (Avg), 335.00 (High), 150.00 (Low)

**Analysis:**

*   The analyst consensus is generally positive (Buy).
*   The average target price suggests a slight upside from the current price of 269.69.
*   The wide range in target prices (150 to 335) highlights the uncertainty surrounding the stock's future performance.

**5) Recent Earnings Analysis**

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-10-30 | 4.25  | 1.59 B$  |
| 2025-07-31 | 3.19  | 1.10 B$  |
| 2025-04-29 | 1.96  | 0.84 B$  |
| 2024-10-29 | 2.92  | 0.89 B$  |
| 2025-10-30 | 2.92  | 0.89 B$  |

**Analysis:**

* The October 30, 2025 and 2024 results appear twice.
*   EPS and revenue have generally been increasing over the last few quarters, indicating positive growth.  The latest quarter (2025-10-30) shows the highest EPS and revenue in the provided data.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $1.59B     | 38.29%        |
| 2025-06-30   | $1.10B     | 45.56%        |
| 2025-03-31   | $0.84B     | 40.78%        |
| 2024-12-31   | $1.51B     | 37.49%        |
| 2024-09-30   | $0.89B     | 50.17%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $9.02B     | 5.06% |
| 2025-06-30   | $8.55B     | 4.00% |
| 2025-03-31   | $8.19B     | 2.56% |
| 2024-12-31   | $7.98B     | 4.93% |
| 2024-09-30   | $7.59B     | 4.12% |

**Analysis:**

*   Revenue has generally increased over the last few quarters, with a slight dip in the most recent quarter compared to the end of 2024.
*   Profit margins are volatile.
*   Equity has been steadily increasing.
*   ROE is also volatile, but generally positive, indicating profitability.

**7) Comprehensive Analysis**

*   **Mixed Performance:** FSLR has underperformed the S&P 500 recently. The CAGR analysis suggests significant volatility.
*   **Positive Financial Trends:** Revenue, EPS, and Equity have generally been increasing, indicating growth.
*   **High Risk:** The high MDD values shows the history of significant drawdowns.
*   **Analyst Optimism:**  Analyst consensus is generally positive, with a "Buy" rating.
*   **Conflicting Indicators:** The MRI is very high (1.0), while the recent performance and high MDD indicate a high degree of risk. The Hybrid Signal is to BUY, but the MRI in the same line is not 1.0, which is confusing.
*   **News Events:** Recent news events show both positive (stock surge, deal with Alphabet, institutional buying) and negative (stock price decline) drivers.

**Overall Recommendation:**

Based on the mixed signals, a neutral to cautiously optimistic stance is warranted.  The financial performance is improving, and analysts are generally positive. However, the historical volatility, underperformance against the S&P 500, and conflicting indicators suggest caution. Investors should carefully consider their risk tolerance and do further research before making an investment decision. The company operates in a sector with strong growth potential (renewable energy), but FSLR's performance requires careful monitoring.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.